Alpha 2.0
Login Register
» Articles » PMID: 11587805

Alternative Vaccine Strategies to Prevent Serogroup B Meningococcal Diseases

Overview
Journal Vaccine
Specialty Allergy & Immunology
Date 2001 Oct 6
PMID 11587805
Citations 6
Authors
J Poolman
F X Berthet
Affiliations
Soon will be listed here.
Citing Articles

Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis.

Awanye A, Chang C, Wheeler J, Chan H, Marsay L, Dold C Sci Rep. 2019; 9(1):6843.

PMID: 31048732 PMC: 6497663. DOI: 10.1038/s41598-019-43139-0.

Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis.

Weynants V, Feron C, Goraj K, Bos M, Denoel P, Verlant V Infect Immun. 2007; 75(11):5434-42.

PMID: 17664268 PMC: 2168297. DOI: 10.1128/IAI.00411-07.

Modeling Neisseria meningitidis metabolism: from genome to metabolic fluxes.

E Baart G, Zomer B, de Haan A, van der Pol L, Beuvery E, Tramper J Genome Biol. 2007; 8(7):R136.

PMID: 17617894 PMC: 2323225. DOI: 10.1186/gb-2007-8-7-r136.

Meningococcal vaccines.

Ruggeberg J, Pollard A Paediatr Drugs. 2004; 6(4):251-66.

PMID: 15339202 DOI: 10.2165/00148581-200406040-00004.

Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains.

Moe G, Zuno-Mitchell P, Hammond S, Granoff D Infect Immun. 2002; 70(11):6021-31.

PMID: 12379678 PMC: 130404. DOI: 10.1128/IAI.70.11.6021-6031.2002.